CareLit · DOI-Nachweis · Pneumologie
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with COPD, stratified by ICS use
DOI 10.1055/s-0036-1572276
Bibliografische Angaben
Nachweis in CareLit
Autor:innenED Bateman, K Chapman, S Rennard, L Rekeda, M Moya, EG Gil
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: A secondary analysis of pooled data, stratified by concomitant inhaled corticosteroid (ICS) use, is presented from ACLIFORM (NCT01462942) and AUGMENT (NCT01437397), two Phase III, 24-week, randomised, double-blind studies of twice-daily (BID) aclidinium/formoterol (AB/FF) fixed-dose combination in patients (pts) with moderate to severe airflow obstruction. Methods: Pts received BID AB/FF 400/12 µg, AB/FF…
Zitieren
Zitierempfehlung
ED Bateman, K Chapman, S Rennard, L Rekeda, M Moya, EG Gil (2016) Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with COPD, stratified by ICS use. Pneumologie (02). https://doi.org/10.1055/s-0036-1572276
Mit CareLit weiterarbeiten